ASCCT Webinars
Upcoming Webinars
Webinars are available for all to attend and watch at no cost. However, after the event the videos are only available to ASCCT members.
Wed, July 24, 2019
10:00 AM - 11:00 AM EDT
Using Quantitative Systems Toxicology (QST): Improving the safety of drugs while reducing animal testing
Presenter: Paul B. Watkins, M.D.
Director, Institute for Drug Safety Sciences, Schools of Pharmacy, Medicine, and Public Health, University of North Carolina – Chapel Hill
Registration link: https://attendee.gotowebinar.com/register/1428823456128168460
September 17, 2019
11:00 AM - 12:00 PM EDT
Nerve-on-a-Chip Platform for Assessing Chemotherapy-induced Peripheral Neuropathy
Presenter: Lowry Curley, AxoSim,Inc
Registration link: https://attendee.gotowebinar.com/register/8913693886943624459
Archived Webinars
Archived videos of past webinars are available to ASCCT members. Contact the Secretary for more information or to suggest a topic for a future webinar.
ASCCT & ESTIV GARD™air Webinar (June 2019) (June 2019)
GARD™air - An in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning
Presenter: Joshua Schmidt, SenzaGen Inc., USA
Co-author: Andy Forreryd, SenzaGen AB, Lund, Sweden
EPA computational tools (May 2019)
New Computational Tools from EPA:
The CompTox Chemicals Dashboard and Generalized Read Across
Presenters: Antony Williams and Grace Patlewicz, EPA
Automated and Integrated Analysis Workflow for Adverse Outcome Pathway Identification, Hypothesis Generation and Risk Assessment (April 2019)
Presenters:
Noffisat O. Oki (1) and Tatyana Doktorova (2)
1Edelweiss Connect Inc, Durham, NC, USA
2Edelweiss Connect Gmbh, Basel, Switzerland
Advancing tools for predictive toxicology (March 2019)
Title: Establishment of bile duct tubular structure mimicking the intrahepatic bile duct morphogenesis for an in vitro bile recovery
Presenters: Astia Rizki-‐Safitri, Marie Shinohara, Minoru Tanaka, and Yasuyuki Sakai
Title: Generation of recombinant human anti-diphtheria toxin neutralizing antibody to replace equine sera
Presenters: Esther Wenzel, Paul Stickings, Jeffrey Brown, Thea Sesardic, Androulla Efstratiou, Michael Hust
Title: Development and Use of Adverse Outcome Pathway (AOP) Networks to Support Assessment of Organ Level Effects
Presenters: Nicoleta Spinu, Mark TD Cronin, Steven J. Enoch, and Judith C Madden
Combining biological and computational approaches (February 2019)
Presenter 1: Daniel Russo, Rutgers University
Title: Developing Mechanism-Based Animal Toxicity Models: A Chemocentric Approach Using Big Data
Presenter 2: Sudin Bhattacharya, Michigan State University
Title: Integrating Genomics and Epigenomics into Predictive Toxicology of the AH Receptor
Nanoceramic pulmonary toxicity & reproducible cell line technology (January 2019)
Award Winners Series: Nanoceramic pulmonary toxicity & reproducible cell line technology
Jan 23, 2019 10:00 AM EST
Presenter 1: Maria João Bessa, PhD candidate, Portuguese National Institute of Health
Title: Pairwise toxicity evaluation of ceramic nanoparticles exposure in human alveolar epithelial A549 cells at submerged and air-liquid cultures
Presenter 2: Tom Wahlicht, PhD, InSCREENeX GmbH
Title: Reproducible in vitro toxicology testing using functional immortalized cells
Development of In Vitro Toxicology Assays using Human Pluripotent Stem Cells and Targeted Metabolomics (December 2018)
Dec 13, 2018 2:00 - 3:00 PM EST
Jessica A. Palmer, Stemina Biomarker Discovery, Inc.
Thorough QT-QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships (November 2018)
Presenter: Weihsueh A. Chiu, PhD, Texas A&M University
Stem Cell-Based in Vitro Models: State-of-the-Art Tools to Predict Drug-Induced Tissue Injury in Humans (October 2018)
Presenter: Prof. Joery De Kock, Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel
Adverse Outcome Pathways: An update on progress and some near-term applications (September 2018)
Presenters:
Kristie Sullivan (1) and Mathieu Vinken (2)
1 Physicians Committee for Responsible Medicine, Washington, DC
2 Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Belgium.